Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Kuopio
AddAiraksinen, O(lavi)
AddAlhava, E.
AddAlhonen, L.
AddAtalay, M(ustafa)
AddCederberg, H.
AddDunkel, L(eo)
AddEskelinen, M(atti)
AddGiniatullin, R.
AddGröhn, O(lli)
AddHarno, K.
AddHartikainen, J(aana).
AddHartikainen, J(uha).
AddHarvima, I.
AddHiltunen, M(ikko)
AddJääskeläinen, J(uha) E.
AddJäkälä, P(ekka)
AddJänne, J.
AddJantunen, E(sa)
AddJärvinen, R.
AddJulkunen, P.
AddKaikkonen, M(inna) U.
AddKauhanen, J(ussi)
AddKivipelto, M(iia)
AddKoistinaho, M.
AddKoivisto, T(imo)
AddKokki, H.
AddKönönen, M.
AddKosma, V(eli)-M(atti)
AddKröger, H.
AddKurl, S(udhir)
AddKuusisto, J(ohanna)
AddLaakso, M(arkku)
AddLakka, T(imo) A.
AddLapinlampi, N(iina)
AddLaukkanen, J(ari) (UEF/KSSHP)
AddLevonen, A(nna)-L(iisa)
AddLindgren, A(ntti) E.
AddLöppönen, H(eikki)
AddMannermaa, A.
AddManninen, H.
AddMecklin, J(ukka)-P(ekka)
AddMoilanen, L(eena)
AddMönkkönen, J.
AddMykkänen, H.
AddNuutinen, J.
AddPaajanen, H.
AddPaananen, J.
AddPalvimo, J.J.
AddPelkonen, J(ukka)
AddPihlajamäki, J(ussi)
AddPihlajamäki, M.
AddPitkänen, A(sla)
AddPunnonen, K.
AddRaatikainen K
AddRauramaa, R.
AddRissanen, T.T.
AddRoine, R(isto) P.
AddRyynänen, O.P.
AddSaarikoski, S.
AddSchwab, U(rsula)
AddSivenius, J.
AddSoininen, H(ilkka)
AddSoininen, P(asi)
AddSorri, I.
AddStancakova, A(lena)
AddSulkava, R.
AddSund, R(eijo)
AddTammi, M.
AddTanila, H(eikki)
AddTiihonen, J(ari)
AddUusaro, A.
AddUusitupa, M.
AddVanninen, R.
AddVaskilampi, T.
AddViinamäki, H(eimo)
AddVirtanen, M(arianna)
AddVoutilainen, R(aimo)
AddVoutilainen, S(ari)
AddWahlfors, J.
AddWirth, T.
AddWong, G.
AddYlä-Herttuala, S(eppo)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.Kosma, V(eli)-M(atti)269 dayssaveRefWorks
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.Kosma, V(eli)-M(atti)275 dayssaveRefWorks
Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.Kosma, V(eli)-M(atti)318 dayssaveRefWorks
High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.Kosma, V(eli)-M(atti)351 dayssaveRefWorks
Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.Kosma, V(eli)-M(atti)472 dayssaveRefWorks
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.Kosma, V(eli)-M(atti)474 dayssaveRefWorks
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.Kosma, V(eli)-M(atti)479 dayssaveRefWorks
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.Kosma, V(eli)-M(atti)484 dayssaveRefWorks
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.Kosma, V(eli)-M(atti)653 dayssaveRefWorks
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.Kosma, V(eli)-M(atti)860 dayssaveRefWorks
Genome-wide association study of germline variants and breast cancer-specific mortality.Kosma, V(eli)-M(atti)973 dayssaveRefWorks
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.Kosma, V(eli)-M(atti)1040 dayssaveRefWorks
Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.Kosma, V(eli)-M(atti)1144 dayssaveRefWorks
Tumor-infiltrating lymphocytes associate with outcome in non-endemic nasopharyngeal carcinoma: a multicenter study.Kosma, V(eli)-M(atti)1189 dayssaveRefWorks
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Kosma, V(eli)-M(atti)1221 dayssaveRefWorks
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.Kosma, V(eli)-M(atti)1340 dayssaveRefWorks
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.Kosma, V(eli)-M(atti)1382 dayssaveRefWorks
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.Kosma, V(eli)-M(atti)1401 dayssaveRefWorks
Body mass index and breast cancer survival: a Mendelian randomization analysis.Kosma, V(eli)-M(atti)1410 dayssaveRefWorks
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.Kosma, V(eli)-M(atti)1444 dayssaveRefWorks
Association analysis identifies 65 new breast cancer risk loci.Kosma, V(eli)-M(atti)1460 dayssaveRefWorks
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Kosma, V(eli)-M(atti)1460 dayssaveRefWorks
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.Kosma, V(eli)-M(atti)1562 dayssaveRefWorks
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.Kosma, V(eli)-M(atti)1624 dayssaveRefWorks
Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.Kosma, V(eli)-M(atti)1682 dayssaveRefWorks
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.Kosma, V(eli)-M(atti)1686 dayssaveRefWorks
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Kosma, V(eli)-M(atti)1716 dayssaveRefWorks
Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.Kosma, V(eli)-M(atti)1739 dayssaveRefWorks
Genome-wide association study identifies novel breast cancer susceptibility loci.Kosma, V(eli)-M(atti)1795 dayssaveRefWorks
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.Kosma, V(eli)-M(atti)1802 dayssaveRefWorks
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.Kosma, V(eli)-M(atti)1814 dayssaveRefWorks
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Kosma, V(eli)-M(atti)1842 dayssaveRefWorks
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.Kosma, V(eli)-M(atti)1849 dayssaveRefWorks
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Kosma, V(eli)-M(atti)1859 dayssaveRefWorks
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Kosma, V(eli)-M(atti)1871 dayssaveRefWorks
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).Kosma, V(eli)-M(atti)1871 dayssaveRefWorks
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.Kosma, V(eli)-M(atti)1872 dayssaveRefWorks
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.Kosma, V(eli)-M(atti)1885 dayssaveRefWorks
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.Kosma, V(eli)-M(atti)1886 dayssaveRefWorks
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Kosma, V(eli)-M(atti)1889 dayssaveRefWorks
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.Kosma, V(eli)-M(atti)1921 dayssaveRefWorks
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Kosma, V(eli)-M(atti)1928 dayssaveRefWorks
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.Kosma, V(eli)-M(atti)1961 dayssaveRefWorks
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.Kosma, V(eli)-M(atti)2004 dayssaveRefWorks
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Kosma, V(eli)-M(atti)2013 dayssaveRefWorks
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Kosma, V(eli)-M(atti)2015 dayssaveRefWorks
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.Kosma, V(eli)-M(atti)2024 dayssaveRefWorks
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Kosma, V(eli)-M(atti)2061 dayssaveRefWorks
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.Kosma, V(eli)-M(atti)2064 dayssaveRefWorks
Genetic predisposition to ductal carcinoma in situ of the breast.Kosma, V(eli)-M(atti)2074 dayssaveRefWorks
 XML / RSS feed
next »